Altoona doctor honored | News
Dr. Alan Kivitz, founder and president of the Altoona Arthritis & Osteoporosis Center and the Altoona Center for Clinical Research was recognized as one of the 2022 Masters of the American College of Rheumatology (ACR) at their annual meeting in October. This prestigious recognition is one of the highest honors that the ACR bestows on its distinguished members.
The ACR sets strict criteria for those who are considered for this elite recognition. “The designation of Master is conferred on ACR members, age 65 or older, who have made outstanding contributions to the field of rheumatology through scholarly achievement and/or service to their patients, students, and the rheumatology profession. These honorees have devoted their long careers to furthering rheumatology research and improving clinical standards in the treatment of rheumatic diseases.”
As a practicing physician, Dr. Kivitz has more than 40 years of experience treating patients with arthritis and rheumatic disorders. He received his medical degree from Albany Medical College in Albany, New York. He completed training in internal medicine at the North Shore University Hospital in Manhasset, New York, and Memorial Sloan Kettering Cancer Center in New York City. Dr. Kivitz then completed his fellowship training in rheumatology at Albany Medical College. He is board certified in internal medicine as well as the subspecialty of rheumatology.
Dr. Kivitz has authored and co-authored more than 1,000 research articles, abstracts, and studies on subjects covering osteoarthritis, osteoporosis, rheumatoid arthritis, and pain management. In addition, his studies have been published in several prestigious medical journals including The New England Journal of Medicine, Pain Medicine, Journal of the American Medical Association, Arthritis & Rheumatology, and Journal of Clinical Rheumatology.
Dr. Kivitz is an active member of the Pennsylvania Medical Society and the American Medical Association. He holds certifications in Human Subjects Protection and HIPAA Research Training and is classified as a Certified Principal Investigator by the Association of Clinical Research Professionals. His research work has focused on the development of newer strategies for treating patients with arthritis and rheumatic disorders. He has served as Principal Investigator or Sub-investigator in more than 1,000 clinical trials
No Byline Policy
Editorial Guidelines
Corrections Policy
Source